PANC Insider Trading Activity and SEC Form 4 Filings
PANC insider trading summary
No open-market insider purchases or sales of Panacos Pharmaceuticals, Inc. (PANC) have been reported on SEC Form 4 in the past 12 months.
Latest PANC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 17, 2007 | Frederick Schmid | Senior VP, Comm Ops & Bus Dev | Buy | $4K (5,000 @ $0.84) |
| Dec 17, 2007 | Graham Allaway | Chief Operating Officer | Buy | $4K (5,000 @ $0.81) |
| Dec 17, 2007 | Frederick Schmid | Senior VP, Comm Ops & Bus Dev | Buy | $8K (10,000 @ $0.82) |
| Dec 17, 2007 | Graham Allaway | Chief Operating Officer | Buy | $4K (5,000 @ $0.81) |
| Dec 17, 2007 | Frederick Schmid | Senior VP, Comm Ops & Bus Dev | Buy | $2K (2,000 @ $0.87) |
| Dec 17, 2007 | Frederick Schmid | Senior VP, Comm Ops & Bus Dev | Buy | $2K (3,000 @ $0.83) |
| Dec 17, 2007 | Graham Allaway | Chief Operating Officer | Buy | $4K (5,000 @ $0.81) |
| Dec 14, 2007 | John D Richards | VP- Manufacturing Operations | Buy | $9K (10,000 @ $0.88) |
| Dec 14, 2007 | Thomas Lategan | VP of Regulatory Affairs | Buy | $7K (8,000 @ $0.88) |
| Dec 14, 2007 | Thomas Lategan | VP of Regulatory Affairs | Buy | $3K (3,530 @ $0.85) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.